{"id":210,"date":"2023-05-19T20:34:48","date_gmt":"2023-05-19T20:34:48","guid":{"rendered":"https:\/\/www.libertymanagement.us\/fda-support\/?p=210"},"modified":"2023-05-19T20:34:48","modified_gmt":"2023-05-19T20:34:48","slug":"drug-master-file-dmf","status":"publish","type":"post","link":"https:\/\/www.libertymanagement.us\/fda-support\/2023\/05\/19\/drug-master-file-dmf\/","title":{"rendered":"Drug Master File (DMF)"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">A <a href=\"https:\/\/www.fdahelp.us\/drug-master-files.html\">Drug\nMaster File (DMF)<\/a> is a confidential submission to FDA to provide detailed\ninformation about the facilities, processes or articles used to manufacture,\nprocess, package or store human <a href=\"https:\/\/www.fdahelp.us\/drugs.html\">drugs<\/a>.\n<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">DMF submissions are not mandatory and DMF applications are neither approved nor rejected by FDA. It is submitted by a drug manufacturer to provide confidential information about the drug&#8217;s quality, safety, and efficacy. The information submitted in a DMF is usually referenced only during the IND, NDA, ANDA or export application. A DMF contains technical information about a drug, including its chemical and physical properties, manufacturing processes, and analytical methods. <\/p>\n\n\n\n<p class=\"wp-block-paragraph\">DMFs are often submitted by drug manufacturers to support\nthe approval of their drug products. DMFs are subject to strict confidentiality\nrequirements and are not publicly available. <\/p>\n\n\n\n<p class=\"wp-block-paragraph\">DMF holders are required to notify FDA of any changes in the\ncontents of DMF, authorized parties, transfer of ownership etc. An annual report\nmust be submitted every year listing all changes since the previous annual\nreport. Foreign DMF holders are required to appoint a <a href=\"https:\/\/www.fdahelp.us\/fda-registration-agent.html\">US Agent<\/a> in their\nsubmissions.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Types of Drug Master Files<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Type I: Manufacturing Site, Facilities, Operating\nProcedures, and Personnel<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Type II: Drug Substance, Drug Substance Intermediate, and\nMaterial Used in Their Preparation, or Drug Product<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Type III: Packaging Material<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Type IV: Excipient, Colorant, Flavor, Essence, or Material\nUsed in Their Preparation<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Type V: FDA Accepted Reference Information<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/www.fdahelp.us\/\">Liberty Management Group\nLtd.<\/a> can help you with DMF submissions &amp; US Agent service. <\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><em>Namrata <\/em><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><em>Regulatory Consultant<\/em><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><em>support@libertymanagement.us<\/em><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"http:\/\/www.fdahelp.us\">www.fdahelp.us<\/a><em><\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>A Drug Master File (DMF) is a confidential submission to FDA to provide detailed information about the facilities, processes or articles used to manufacture, process, package or store human drugs. DMF submissions are not mandatory and DMF applications are neither approved nor rejected by FDA. It is submitted by a drug manufacturer to provide confidential &hellip; <a href=\"https:\/\/www.libertymanagement.us\/fda-support\/2023\/05\/19\/drug-master-file-dmf\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Drug Master File (DMF)&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[72,73,37],"class_list":["post-210","post","type-post","status-publish","format-standard","hentry","category-uncategorized","tag-dmf","tag-drug-master-file","tag-us-agent"],"_links":{"self":[{"href":"https:\/\/www.libertymanagement.us\/fda-support\/wp-json\/wp\/v2\/posts\/210","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.libertymanagement.us\/fda-support\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.libertymanagement.us\/fda-support\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.libertymanagement.us\/fda-support\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.libertymanagement.us\/fda-support\/wp-json\/wp\/v2\/comments?post=210"}],"version-history":[{"count":1,"href":"https:\/\/www.libertymanagement.us\/fda-support\/wp-json\/wp\/v2\/posts\/210\/revisions"}],"predecessor-version":[{"id":211,"href":"https:\/\/www.libertymanagement.us\/fda-support\/wp-json\/wp\/v2\/posts\/210\/revisions\/211"}],"wp:attachment":[{"href":"https:\/\/www.libertymanagement.us\/fda-support\/wp-json\/wp\/v2\/media?parent=210"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.libertymanagement.us\/fda-support\/wp-json\/wp\/v2\/categories?post=210"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.libertymanagement.us\/fda-support\/wp-json\/wp\/v2\/tags?post=210"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}